Crosstalk Between Peripheral Innervation and Pancreatic Ductal Adenocarcinoma

Neurosci Bull. 2023 Nov;39(11):1717-1731. doi: 10.1007/s12264-023-01082-1. Epub 2023 Jun 22.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive lethal malignancy, characterized by late diagnosis, aggressive growth, and therapy resistance, leading to a poor overall prognosis. Emerging evidence shows that the peripheral nerve is an important non-tumor component in the tumor microenvironment that regulates tumor growth and immune escape. The crosstalk between the neuronal system and PDAC has become a hot research topic that may provide novel mechanisms underlying tumor progression and further uncover promising therapeutic targets. In this review, we highlight the mechanisms of perineural invasion and the role of various types of tumor innervation in the progression of PDAC, summarize the potential signaling pathways modulating the neuronal-cancer interaction, and discuss the current and future therapeutic possibilities for this condition.

Keywords: Cancer-neuroscience; PDAC; Pain; Peripheral innervation.

Publication types

  • Review

MeSH terms

  • Carcinoma, Pancreatic Ductal* / drug therapy
  • Carcinoma, Pancreatic Ductal* / metabolism
  • Carcinoma, Pancreatic Ductal* / pathology
  • Humans
  • Pancreatic Neoplasms* / metabolism
  • Pancreatic Neoplasms* / pathology
  • Pancreatic Neoplasms* / therapy
  • Peripheral Nerves / metabolism
  • Signal Transduction
  • Tumor Microenvironment